Population pharmacokinetics study of polymyxin E sodium mesylate

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300072099

Enrollment

Unknown

Registered

2023-06-02

Start date

2023-06-20

Completion date

Unknown

Last updated

2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection of drug-resistant gram-negative bacteria

Interventions

Group of patients infected with gram-negative bacteria:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Age =18 years old (2) Patients infected with gram-negative bacteria (3) Patients treated with polymyxin E sodium mesylate

Exclusion criteria

Exclusion criteria: (1) Patients with polymyxin E sodium mesylate allergy (2) Pregnant women

Design outcomes

Primary

Measure	Time frame
Blood concentrations of Polymyxin E sodium mesylate;	—

Countries

China

Contacts

Public ContactLiu Dong

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

ld2069@outlook.com027-83663643

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026